|
1
|
Mazzocca A, Giannelli G and Antonaci S:
Involvement of ADAMs in tumorigenesis and progression of
hepatocellular carcinoma: Is it merely fortuitous or a real
pathogenic link? Biochim Biophys Acta. 1806:74–81. 2010.PubMed/NCBI
|
|
2
|
Jacobsen J, Visse R, Sørensen HP, Enghild
JJ, Brew K, Wewer UM and Nagase H: Catalytic properties of ADAM12
and its domain deletion mutants. Biochemistry. 47:537–547. 2008.
View Article : Google Scholar
|
|
3
|
Ieguchi K, Tomita T, Omori T, Komatsu A,
Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A and Maru Y:
ADAM12-cleaved ephrin-A1 contributes to lung metastasis. Oncogene.
33:2179–2190. 2014. View Article : Google Scholar
|
|
4
|
Kerna I, Kisand K, Suutre S, Murde M and
Tamm A, Kumm J and Tamm A: The ADAM12 is upregulated in synovitis
and postin-flammatory fibrosis of the synovial membrane in patients
with early radiographic osteoarthritis. Joint Bone Spine. 81:51–56.
2014. View Article : Google Scholar
|
|
5
|
Higashiyama S: Membrane-anchored
heparin-binding EGF-like growth factor processing by ADAM12 in
cardiac hypertrophy. Nihon Rinsho. 61:767–775. 2003.In Japanese.
PubMed/NCBI
|
|
6
|
Roy R, Rodig S, Bielenberg D, Zurakowski D
and Moses MA: ADAM12 transmembrane and secreted isoforms promote
breast tumor growth: A distinct role for ADAM12-S protein in tumor
metastasis. J Biol Chem. 286:20758–20768. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peduto L, Reuter VE, Sehara-Fujisawa A,
Shaffer DR, Scher HI and Blobel CP: ADAM12 is highly expressed in
carcinoma-associated stroma and is required for mouse prostate
tumor progression. Oncogene. 25:5462–5466. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shao S, Li Z, Gao W, Yu G, Liu D and Pan
F: ADAM-12 as a diagnostic marker for the proliferation, migration
and invasion in patients with small cell lung cancer. PLoS One.
9:e859362014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Le Pabic H, Bonnier D, Wewer UM, Coutand
A, Musso O, Baffet G, Clément B and Théret N: ADAM12 in human liver
cancers: TGF-beta-regulated expression in stellate cells is
associated with matrix remodeling. Hepatology. 37:1056–1066. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ray BK, Dhar S, Shakya A and Ray A:
Z-DNA-forming silencer in the first exon regulates human ADAM-12
gene expression. Proc Natl Acad Sci USA. 108:103–108. 2011.
View Article : Google Scholar :
|
|
11
|
Li H, Solomon E, Duhachek Muggy S, Sun D
and Zolkiewska A: Metalloprotease-disintegrin ADAM12 expression is
regulated by Notch signaling via microRNA-29. J Biol Chem.
286:21500–21510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Díaz B, Yuen A, Iizuka S, Higashiyama S
and Courtneidge SA: Notch increases the shedding of HB-EGF by
ADAM12 to poten-tiate invadopodia formation in hypoxia. J Cell
Biol. 201:279–292. 2013. View Article : Google Scholar
|
|
13
|
Li Z, Guo Y, Jiang H, Zhang T, Jin C,
Young CY and Yuan H: Differential regulation of MMPs by E2F1, Sp1
and NF-kappa B controls the small cell lung cancer invasive
phenotype. BMC Cancer. 14:2762014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ioannou M, Papamichali R, Kouvaras E,
Mylonis I, Vageli D, Kerenidou T, Barbanis S, Daponte A, Simos G,
Gourgoulianis K, et al: Hypoxia inducible factor-1 alpha and
vascular endothelial growth factor in biopsies of small cell lung
carcinoma. Lung. 187:321–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harris HA, Murrills RJ and Komm BS:
Expression of meltrin-alpha mRNA is not restricted to fusagenic
cells. J Cell Biochem. 67:136–142. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kurisaki T, Masuda A, Osumi N, Nabeshima Y
and Fujisawa-Sehara A: Spatially- and temporally-restricted
expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse
embryo. Mech Dev. 73:211–215. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Borneman A, Kuschel R and Fujisawa-Sehara
A: Analysis for transcript expression of meltrin alpha in normal,
regenerating, and denervated rat muscle. J Muscle Res Cell Motil.
21:475–480. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Galliano MF, Huet C, Frygelius J, Polgren
A, Wewer UM and Engvall E: Binding of ADAM12, a marker of skeletal
muscle regeneration, to the muscle-specific actin-binding protein,
alpha -actinin-2, is required for myoblast fusion. J Biol Chem.
275:13933–13939. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao Y, Zhao Z, Gruszczynska-Biegala J and
Zolkiewska A: Role of metalloprotease disintegrin ADAM12 in
determination of quiescent reserve cells during myogenic
differentiation in vitro. Mol Cell Biol. 23:6725–6738. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abe E, Mocharla H, Yamate T, Taguchi Y and
Manolagas SC: Meltrin-alpha, a fusion protein involved in
multinucleated giant cell and osteoclast formation. Calcif Tissue
Int. 64:508–515. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Verrier S, Hogan A, McKie N and Horton M:
ADAM gene expression and regulation during human osteoclast
formation. Bone. 35:34–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu C, Li L, Zhao J, Fan Q, Tian WX and He
RQ: Effect of α2M on earthworm fibrinolytic enzyme III-1
from Lumbricus rubellus. Int J Biol Macromol. 31:71–77. 2002.
View Article : Google Scholar
|
|
23
|
Gilpin BJ, Loechel F, Mattei MG, Engvall
E, Albrechtsen R and Wewer UM: A novel, secreted form of human ADAM
12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem.
273:157–166. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tani N, Higashiyama S, Kawaguchi N,
Madarame J, Ota I, Ito Y, Ohoka Y, Shiosaka S, Takada Y and
Matsuura N: Expression level of integrin alpha 5 on tumour cells
affects the rate of metastasis to the kidney. Br J Cancer.
88:327–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kveiborg M, Albrechtsen R, Rudkjaer L, Wen
G, Damgaard-Pedersen K and Wewer UM: ADAM12-S stimulates bone
growth in transgenic mice by modulating chondrocyte proliferation
and maturation. J Bone Miner Res. 21:1288–1296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bourd-Boittin K, Le Pabic H, Bonnier D,
L'Helgoualc'h A and Théret N: RACK1, a new ADAM12 interacting
protein. Contribution to liver fibrogenesis. J Biol Chem.
283:26000–26009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wyllie AH: E2F1 selects tumour cells for
both life and death. J Pathol. 198:139–141. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson JL, Pillai S, Pernazza D, Sebti
SM, Lawrence NJ and Chellappan SP: Regulation of matrix
metalloproteinase genes by E2F transcription factors: Rb-Raf-1
interaction as a novel target for metastatic disease. Cancer Res.
72:516–526. 2012. View Article : Google Scholar :
|
|
29
|
Ji W, Zhang W and Xiao W: E2F-1 directly
regulates thrombos-pondin 1 expression. PLoS One. 5:e134422010.
View Article : Google Scholar
|
|
30
|
Minato Y, Tashiro E, Kanai M, Nihei Y,
Kodama Y and Imoto M: Transcriptional regulation of a new variant
of human platelet-derived growth factor receptor alpha transcript
by E2F-1. Gene. 403:89–97. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pillai S, Kovacs M and Chellappan S:
Regulation of vascular endothelial growth factor receptors by Rb
and E2F1: Role of acetylation. Cancer Res. 70:4931–4940. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lavrrar JL and Farnham PJ: The use of
transient chromatin immunoprecipitation assays to test models for
E2F1-specific transcriptional activation. J Biol Chem.
279:46343–46349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin VX, Rabinovich A, Squazzo SL, Green R
and Farnham PJ: A computational genomics approach to identify
cis-regulatory modules from chromatin immunoprecipitation
microarray data - a case study using E2F1. Genome Res.
16:1585–1595. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weinmann AS, Bartley SM, Zhang T, Zhang MQ
and Farnham PJ: Use of chromatin immunoprecipitation to clone novel
E2F target promoters. Mol Cell Biol. 21:6820–6832. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wells J, Graveel CR, Bartley SM, Madore SJ
and Farnham PJ: The identification of E2F1-specific target genes.
Proc Natl Acad Sci USA. 99:3890–3895. 2002. View Article : Google Scholar : PubMed/NCBI
|
